Case Report

Vol. 25 No. 1 (2021): Endocrinology Research and Practice
DOI: https://doi.org/10.25179/tjem.2020-80188

Article Sidebar

Full Text PDF
Published: Mar 1, 2021
Keywords:
Nodular vasculitis; dapagliflozin; antinuclear antibodies; sodium-glucose cotransporter-2 inhibitors; diabetes mellitus

Main Article Content

Muhammet KOCABAŞ
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
Zeliha YARAR
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
Hatice ÇALIŞKAN BURGUCU
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
Harun AYDEMİR
Department of Rheumatology, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
Melia KARAKÖSE
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
Feridun KARAKURT
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
İlker ÇORDAN
Clinic of Endocrinology and Metabolism, Edirne Sultan 1. Murat State Hospital, Edirne, TURKEY
Mustafa KULAKSIZOĞLU
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
Mustafa CAN
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY

A Case Report of Dapagliflozin-Induced Nodular Vasculitis

Main Article Content

Muhammet KOCABAŞ
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
Zeliha YARAR
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
Hatice ÇALIŞKAN BURGUCU
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
Harun AYDEMİR
Department of Rheumatology, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
Melia KARAKÖSE
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
Feridun KARAKURT
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
İlker ÇORDAN
Clinic of Endocrinology and Metabolism, Edirne Sultan 1. Murat State Hospital, Edirne, TURKEY
Mustafa KULAKSIZOĞLU
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY
Mustafa CAN
Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY

Abstract

ABSTRACT



Nodular vasculitis (NV), first described by Montgomery in 1945 for erythema induratum-like lesions, is a rare form of panniculitis that is particularly localized on the calves. Characterized by plaques and erythematous nodules, NV may often show ulceration and draining. It is known as a reactive disease associated with many causative factors. Several NV cases due to infectious or non-infectious causative factors have been reported, but no case of NV due to sodium-glucose cotransporter-2 inhibitors (SGLT2i) has yet been reported. In this case report, we presented a case diagnosed with NV, who presented with tender, erythematous, eroded plaques with hemorrhagic-purulent discharge on both legs during treatment with dapagliflozin (an SGLT2i).



 



 


Article Details